This statistic displays the share of GDP expenditure on pharmaceuticals and other medical non-durables in Portugal from 2005 to 2015. The share of GDP expenditure on pharmaceuticals and other medical non-durables decreased slightly during the period concerned, falling to 1.4 percent since 2013.
Share of GDP expenditure on pharmaceuticals and other medical non-durables in Portugal from 2005 to 2015
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic GDP expenditure on pharmaceuticals and medical non-durables in Hungary 2005-2015
- Premium Statistic GDP expenditure on pharmaceuticals and medical non-durables in Germany 2005-2015
- Premium Statistic Health expenditure on pharmaceuticals and medical non-durables in Hungary 2005-2015
- Premium Statistic GDP expenditure on pharmaceuticals and other medical non-durables in Bulgaria 2005-15
- Premium Statistic Health expenditure on pharmaceuticals and medical non-durables in the Netherlands
- Premium Statistic Health expenditure on pharmaceuticals and medical non-durables in Bulgaria 2005-2015
- Premium Statistic Health expenditure on pharmaceuticals and medical non-durables in Germany 2005-2015
- Premium Statistic Health expenditure on pharmaceuticals and medical non-durables in Portugal 2005-2015
- Premium Statistic Health expenditure on pharmaceuticals and medical non-durables in Greece 2005-2015
- Premium Statistic GDP expenditure on pharmaceuticals and other medical non-durables in Poland 2005-2015
About the region
10
- Basic Statistic Production value of pharmaceutical products & preparations in Portugal 2012-2021
- Basic Statistic Antidepressants pharmaceutical consumption in Portugal 2009-2022
- Premium Statistic GDP expenditure on health administration and health insurance in Portugal 2005-2015
- Basic Statistic Diabetes pharmaceutical consumption in Portugal 2009-2022
- Premium Statistic Value of pharmaceutical sales in Portugal 2003-2022
- Premium Statistic Value share of generic pharmaceuticals market in Portugal 2002-2022
- Basic Statistic Cardiovascular system pharmaceutical consumption in Portugal 2009-2022
- Premium Statistic Volume share of generic pharmaceuticals market in Portugal 2004-2022
- Basic Statistic Hospitals in Portugal 2000-2021
- Premium Statistic Average length of stay in hospital in Portugal 2012-2021
Other regions
10
- Premium Statistic Health expenditure on pharmaceuticals and medical non-durables in Romania 2005-2015
- Premium Statistic Expenditure for self-medication products in Italy 2013-2022
- Premium Statistic Predicted oncology spending in 2023, by region
- Basic Statistic U.S. health care spending growth 2010-2019, by sector
- Premium Statistic Spending on pharmaceuticals in the United Kingdom (UK) 2003-2014
- Premium Statistic Leading pharmaceutical companies in Norway 2021, by market share
- Basic Statistic Expenditure on nonprescription pharmaceuticals in Sweden 2009-2022
- Basic Statistic Number of employees at LEO Pharma 2009-2023
- Premium Statistic Drug production value of cardiovascular agents Japan 2022, by category
- Basic Statistic Total public drug program spending in Canada by therapy 2022
Related statistics
10
- Premium Statistic Avoidable delayed treatment U.S. healthcare costs by settings of care 2012
- Premium Statistic Avoidable U.S. healthcare costs due to delayed treatment by disease 2012
- Premium Statistic Avoidable antibiotics outpatient prescriptions in the U.S. by disease 2012
- Premium Statistic Avoidable U.S. medication error healthcare costs by settings of care 2012
- Premium Statistic Efficiency rate of generics in the U.S. 2007-2012
- Premium Statistic Supplementary Medical Insurance Medicare benefit payments 2015-2022
- Premium Statistic Forecasted development in Medicare enrollment 2000-2090
- Basic Statistic Median Medicaid/CHIP eligibility threshold January 2023
- Basic Statistic Recoveries and expenditures from fraud cases under Medicaid 2022
- Basic Statistic Provider types with highest number of convictions for fraud under Medicaid 2022
Further related statistics
10
- Medicaid long-term care services expenditures by type of service 1990-21
- Key figures on established biotech centers worldwide 2012-2016
- Global pharmaceutical pipeline by therapy area 2013-2017
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Location of death among hospice patients in the U.S. 2018
- Size of U.S. hospices by number of admissions 2012-2014
- Expenditure worldwide on diabetes by market 2013-2018
- Standard Unit medicine use per capita in the U.S. 2007-2011
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- AstraZeneca's revenue from top product Pulmicort 2006-2023
Further Content: You might find this interesting as well
Statistics
- Medicaid long-term care services expenditures by type of service 1990-21
- Key figures on established biotech centers worldwide 2012-2016
- Global pharmaceutical pipeline by therapy area 2013-2017
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Location of death among hospice patients in the U.S. 2018
- Size of U.S. hospices by number of admissions 2012-2014
- Expenditure worldwide on diabetes by market 2013-2018
- Standard Unit medicine use per capita in the U.S. 2007-2011
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- AstraZeneca's revenue from top product Pulmicort 2006-2023
European Commission. (June 7, 2019). Share of GDP expenditure on pharmaceuticals and other medical non-durables in Portugal from 2005 to 2015 [Graph]. In Statista. Retrieved April 20, 2024, from https://www.statista.com/statistics/682042/gdp-expenditure-on-pharmaceuticals-in-portugal/
European Commission. "Share of GDP expenditure on pharmaceuticals and other medical non-durables in Portugal from 2005 to 2015." Chart. June 7, 2019. Statista. Accessed April 20, 2024. https://www.statista.com/statistics/682042/gdp-expenditure-on-pharmaceuticals-in-portugal/
European Commission. (2019). Share of GDP expenditure on pharmaceuticals and other medical non-durables in Portugal from 2005 to 2015. Statista. Statista Inc.. Accessed: April 20, 2024. https://www.statista.com/statistics/682042/gdp-expenditure-on-pharmaceuticals-in-portugal/
European Commission. "Share of Gdp Expenditure on Pharmaceuticals and Other Medical Non-durables in Portugal from 2005 to 2015." Statista, Statista Inc., 7 Jun 2019, https://www.statista.com/statistics/682042/gdp-expenditure-on-pharmaceuticals-in-portugal/
European Commission, Share of GDP expenditure on pharmaceuticals and other medical non-durables in Portugal from 2005 to 2015 Statista, https://www.statista.com/statistics/682042/gdp-expenditure-on-pharmaceuticals-in-portugal/ (last visited April 20, 2024)
Share of GDP expenditure on pharmaceuticals and other medical non-durables in Portugal from 2005 to 2015 [Graph], European Commission, June 7, 2019. [Online]. Available: https://www.statista.com/statistics/682042/gdp-expenditure-on-pharmaceuticals-in-portugal/